Get the latest Science News and Discoveries

ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform - EurekAlert


Another ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) treatment trial is open as part of the ComboMATCH precision medicine study platform. ComboMATCH-E5 is evaluating treatment for patients with <em>KRAS</em> G12C-mutated advanced solid tumors with two different targeted drugs given together.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of ACRIN

ACRIN

Photo of Trial

Trial

Related news:

News photo

Turning trash into treasure: breakthrough innovations in PET plastic upcycling - EurekAlert

News photo

GP and Clinical Lecturer, Dr James Gill, calls for personalized NHS approach to weight-loss in response to ZOE 'anti ... - EurekAlert

News photo

Decoding the complex genetic network of antimicrobial resistance in Campylobacter jejuni using advanced gene ... - EurekAlert